2022-2023 Drug Updates: Investigational Therapeutics in the Pipeline
- PMID: 39297063
- PMCID: PMC11406313
- DOI: 10.6004/jadpro.2024.15.3.5
2022-2023 Drug Updates: Investigational Therapeutics in the Pipeline
Abstract
During JADPRO Live 2023, Sandra Cuellar, PharmD, BCOP, FHOPA, FASHP, discussed investigational therapeutic agents in the drug development pipeline. Dr. Cuellar highlighted new drug classes, novel mechanisms of action, and safety profiles that advanced practitioners should be aware of.
© 2024 BroadcastMed LLC.
Conflict of interest statement
Dr. Cuellar received honoraria for serving on speakers bureaus for Mirati and Genentech.
LinkOut - more resources
Full Text Sources